{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-19T12:22:40.823533+00:00",
  "news": [
    {
      "title": "Living life with cystic fibrosis: The Circle of Care grant - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQOXNkbmF5TTBNd0tSY2Q0ZzU5d1hEdm5TekdDVVRTZXc1Wkh4NDg3dUpnbWtOcTA5YjBxWGhfMjZhR0taQW43NXotWlpGZExTdElzQWYwUVVaM2lWZ1k4WXRSWV9wS1VialBETUlaTlhnMlRxb1V6Q1R4RDBOdTBQNg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxQOXNkbmF5TTBNd0tSY2Q0ZzU5d1hEdm5TekdDVVRTZXc1Wkh4NDg3dUpnbWtOcTA5YjBxWGhfMjZhR0taQW43NXotWlpGZExTdElzQWYwUVVaM2lWZ1k4WXRSWV9wS1VialBETUlaTlhnMlRxb1V6Q1R4RDBOdTBQNg?oc=5\" target=\"_blank\">Living life with cystic fibrosis: The Circle of Care grant</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-08-18T13:32:30+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZkNIU0JuZWlPeHlqZ2hFREpXTmk2RDdGd250NnBOWU5lR1RCTVRxY0ZUSWRhNUpYX2JZNnBOcDA1RTdTOGhWWW1QdzJteElVQW1yb1ZQLVlhYTh3c1NjbFhuZXkyRE9TaTJueWtSTnpMaG9YT09faFdQUmpDRmtERDZGTjZhOGpa?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZkNIU0JuZWlPeHlqZ2hFREpXTmk2RDdGd250NnBOWU5lR1RCTVRxY0ZUSWRhNUpYX2JZNnBOcDA1RTdTOGhWWW1QdzJteElVQW1yb1ZQLVlhYTh3c1NjbFhuZXkyRE9TaTJueWtSTnpMaG9YT09faFdQUmpDRmtERDZGTjZhOGpa?oc=5\" target=\"_blank\">Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-19T03:19:54+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged - MSN",
      "link": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNZkRSWW1rTXlnbmRLZFFrbzRfTGQ0SjJ3a1VXTXpreF9RUFJ6UEFlaU94M0hMMFhDOGYtUV8wcFNTcmhYVEQxcW03dWJaUlNzclF4U0hEZG1vVEk2Uy1fWWVxa3ZXRTg4TmN1V1JtXzkybV9FUDNQNEhmQnpOR0dHcEFSWlBBOUpQbE52ODFHM0dXSkVBQ0NTdW1vcXVwQXBJanN3NndHb08yeHVMT0ZMaGcwb1pfTnFSTnphTEk1MmptdmNEbUVFbE55Rjh6Z1RCSXpkUVh0XzViYjJGcW1UUVRMa3UzQXRw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNZkRSWW1rTXlnbmRLZFFrbzRfTGQ0SjJ3a1VXTXpreF9RUFJ6UEFlaU94M0hMMFhDOGYtUV8wcFNTcmhYVEQxcW03dWJaUlNzclF4U0hEZG1vVEk2Uy1fWWVxa3ZXRTg4TmN1V1JtXzkybV9FUDNQNEhmQnpOR0dHcEFSWlBBOUpQbE52ODFHM0dXSkVBQ0NTdW1vcXVwQXBJanN3NndHb08yeHVMT0ZMaGcwb1pfTnFSTnphTEk1MmptdmNEbUVFbE55Rjh6Z1RCSXpkUVh0XzViYjJGcW1UUVRMa3UzQXRw?oc=5\" target=\"_blank\">Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-08-19T06:04:19+00:00",
      "source": "MSN"
    },
    {
      "title": "Stock Analysis | Vertex Pharmaceuticals Outlook - A Bullish Setup with Strong Analyst Support - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNYWF3V1hKc3lxdHBSYmtCdlJrVng2bkVOb1FhNm44dmxQVDRacTY2MEhEMUg4dl8zRDlHY0JTTmNWbDdDWWN5OWx5QkNaS0dKWW55bGtkWEdMRl9Zb3gyZFpLNzN0TGJxbmxyeWIzcTlNUVduUDA1MXUwdWlIdEMtZEIzQWNFOGVvZXFzekNuZ3J5LUtxS2Q4SkN6a2trZVVzODBWN19PWUZrZWNzc3pmTDNQbWlodENk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNYWF3V1hKc3lxdHBSYmtCdlJrVng2bkVOb1FhNm44dmxQVDRacTY2MEhEMUg4dl8zRDlHY0JTTmNWbDdDWWN5OWx5QkNaS0dKWW55bGtkWEdMRl9Zb3gyZFpLNzN0TGJxbmxyeWIzcTlNUVduUDA1MXUwdWlIdEMtZEIzQWNFOGVvZXFzekNuZ3J5LUtxS2Q4SkN6a2trZVVzODBWN19PWUZrZWNzc3pmTDNQbWlodENk?oc=5\" target=\"_blank\">Stock Analysis | Vertex Pharmaceuticals Outlook - A Bullish Setup with Strong Analyst Support</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-19T03:24:40+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex Pharma CEO Buys the Stock Dip - Barron's",
      "link": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5\" target=\"_blank\">Vertex Pharma CEO Buys the Stock Dip</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron's</font>",
      "published": "2025-08-15T21:52:00+00:00",
      "source": "Barron's"
    },
    {
      "title": "Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPT3k5b0hjTXczM3VPY2RHYUh0TzEzV2wyQUJ1aDRmbm13eDF5MEpYQXpYaFpfYlJobk96VXpLbURZM3FtRHhoUjRzWHBlUGQ0RXgyX21lb0R1c3JpT2lfLVRjVDBDTTQxS2VONlIxekN4NFJqOFhZRXZhVGt5LTlYckZmbERObHpZdE41aGZzNWtQRlR1YXUybUgzbTJ0U1F4MDBxRjJJOUMwRU1ObnFZX3M2eDZKYzZQVXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxPT3k5b0hjTXczM3VPY2RHYUh0TzEzV2wyQUJ1aDRmbm13eDF5MEpYQXpYaFpfYlJobk96VXpLbURZM3FtRHhoUjRzWHBlUGQ0RXgyX21lb0R1c3JpT2lfLVRjVDBDTTQxS2VONlIxekN4NFJqOFhZRXZhVGt5LTlYckZmbERObHpZdE41aGZzNWtQRlR1YXUybUgzbTJ0U1F4MDBxRjJJOUMwRU1ObnFZX3M2eDZKYzZQVXc?oc=5\" target=\"_blank\">Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-18T13:01:19+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "The 3 Things That Matter for Vertex Pharmaceuticals Now - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNWl9vejVmVmZ1bzVtRlBYYUI4X3lwTXhidXU4ZUExQWV0YXRtdXlsaFduSy1xb0dRc1otM0JUUjlTTmhmVERDWnBsVnhVVG53QnRzc3JmZGdQV0RnS1g0cS1lN3ZMRjFncFB1VGZ4bVpWMEw0d3B0bTNQeEVDMjFiVTFyMDY2Q3VDQ3JhVXI3N0FQTnFPLW4xag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNWl9vejVmVmZ1bzVtRlBYYUI4X3lwTXhidXU4ZUExQWV0YXRtdXlsaFduSy1xb0dRc1otM0JUUjlTTmhmVERDWnBsVnhVVG53QnRzc3JmZGdQV0RnS1g0cS1lN3ZMRjFncFB1VGZ4bVpWMEw0d3B0bTNQeEVDMjFiVTFyMDY2Q3VDQ3JhVXI3N0FQTnFPLW4xag?oc=5\" target=\"_blank\">The 3 Things That Matter for Vertex Pharmaceuticals Now</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-07-28T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5\" target=\"_blank\">Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investor's Business Daily"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T11:55:03+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex Reports Second Quarter 2025 Financial Results - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5\" target=\"_blank\">Vertex Reports Second Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "AInvest"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-18",
      "close": 389.8800048828125
    },
    "history": [
      {
        "date": "2025-08-08",
        "close": 366.5400085449219
      },
      {
        "date": "2025-08-11",
        "close": 374.4599914550781
      },
      {
        "date": "2025-08-12",
        "close": 387.7699890136719
      },
      {
        "date": "2025-08-13",
        "close": 395.9200134277344
      },
      {
        "date": "2025-08-14",
        "close": 390.29998779296875
      },
      {
        "date": "2025-08-15",
        "close": 392.7900085449219
      },
      {
        "date": "2025-08-18",
        "close": 389.8800048828125
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}